DURECT Corporation Presenting at the Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference
May 08, 2007
CUPERTINO, CA, May 8, 2007/ PRNewswire-First Call via COMTEX/ -- DURECT Corporation (Nasdaq: DRRX) announced today that it would present at the Acumen BioFin Rodman & Renshaw 4th Annual Global Healthcare Conference to be held on May 14-15 at the Le Meridien Beach Plaza Hotel in Monte Carlo, Monaco. James E. Brown, President and CEO, will be presenting at the conference on May 14th at 10:00 a.m. Eastern Time / 4:00 p.m. Central European Time.
A live audio webcast of the presentation will be available by accessing DURECT’s homepage at www.durect.com and clicking “Investor Relations.” If you are unable to participate during the live webcast, the call will be archived on DURECT’s website under Audio Archive in the “Investor Relations” section.
About DURECT Corporation
DURECT Corporation is an emerging specialty pharmaceutical company developing pharmaceutical systems based on its proprietary drug delivery platform technologies. The Company currently has a number of late-stage pharmaceutical products in development addressing large markets in pain management, with a number of research programs underway targeting chronic disease and other therapeutic areas. For more information, please visit www.durect.com.
SOURCE: DURECT Corporation CONTACT: Matthew J. Hogan, Chief Financial Officer, +1-408-777-4936
Media Contact: Feinstein Kean Healthcare Jeremiah Hall, Senior Vice President, +415 677-2700, jeremiah.hall@fkhealth.com
|
|
